Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Assets: 2022-2024

Historic Assets for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $864.6 million.

  • NewAmsterdam Pharma Co N.V's Assets rose 79.06% to $786.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $786.4 million, marking a year-over-year increase of 79.06%. This contributed to the annual value of $864.6 million for FY2024, which is 149.10% up from last year.
  • As of FY2024, NewAmsterdam Pharma Co N.V's Assets stood at $864.6 million, which was up 149.10% from $347.1 million recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's 5-year Assets high stood at $864.6 million for FY2024, and its period low was $531,583 during FY2022.
  • Moreover, its 3-year median value for Assets was $347.1 million (2023), whereas its average is $404.1 million.
  • Data for NewAmsterdam Pharma Co N.V's Assets shows a peak YoY skyrocketed of 65,194.98% (in 2023) over the last 5 years.
  • NewAmsterdam Pharma Co N.V's Assets (Yearly) stood at $531,583 in 2022, then skyrocketed by 65,194.98% to $347.1 million in 2023, then soared by 149.10% to $864.6 million in 2024.